China Cord Blood Corp  

(Public, NYSE:CO)   Watch this stock  
Find more results for CO
+0.02 (0.47%)
Dec 19 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 4.25 - 4.41
52 week 3.70 - 5.70
Open 4.31
Vol / Avg. 30,679.00/71,988.00
Mkt cap 312.90M
P/E 16.19
Div/yield     -
EPS 0.26
Shares 73.00M
Beta 1.07
Inst. own 30%
Feb 24, 2015
Q3 2015 China Cord Blood Corp Earnings Release (Estimated) Add to calendar
Dec 11, 2014
China Cord Blood Corp Annual Shareholders Meeting
Nov 26, 2014
Q2 2015 China Cord Blood Corp Earnings Call - Webcast
Nov 25, 2014
Q2 2015 China Cord Blood Corp Earnings Release
Nov 5, 2014
China Cord Blood Corp at Citi China Investor Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin 19.30% 23.13%
Operating margin 39.24% 40.49%
EBITD margin - 46.96%
Return on average assets 3.22% 4.01%
Return on average equity 8.21% 8.75%
Employees 944 -
CDP Score - -


48th Floor, Bank of China Tower 1 Garden Road, Central
Hong Kong S.A.R.,
Hong Kong
+85236058180 (Phone)
+85236058181 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


China Cord Blood Corporation (CCBC) is a provider of cord blood storage services in China. The Company is engaged in the provision of umbilical cord blood storage and ancillary services in its cord blood banks in the People�s Republic of China (PRC). As of March 31, 2013, the Company operated three cord blood banks in the Beijing municipality and Guangdong province and the Zhejiang province, the PRC. The Company provides cord blood storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Officers and directors

Yuen Kam Chairman of the Board
Age: 51
Bio & Compensation  - Reuters
Ting Zheng Chief Executive Officer, Director
Age: 41
Bio & Compensation  - Reuters
Albert Chen Chief Financial Officer, Director
Age: 37
Bio & Compensation  - Reuters
Rui Arashiyama Chief Executive Officer - Guangdong and Zhejiang Divisions
Age: 54
Bio & Compensation  - Reuters
Yue Deng Chief Executive Officer - Beijing Division
Age: 43
Bio & Compensation  - Reuters
Xin Xu Chief Technology Officer
Age: 59
Bio & Compensation  - Reuters
Mark D. Chen Non-Executive Independent Director
Age: 45
Bio & Compensation  - Reuters
Ken Lu Non-Executive Independent Director
Age: 51
Bio & Compensation  - Reuters
Jennifer J. Weng Non-Executive Independent Director
Age: 45
Bio & Compensation  - Reuters
Julian Juul Wolhardt CPA Independent Non-executive Director
Age: 40
Bio & Compensation  - Reuters